What changed in this filing

/stocks — the workspaceLOADING

Item 5. Other Information

2011-09-21 compared with 2010-07-30 · 47 added, 13 removed, 3 unchanged (95% of the section changed)

Other Information.

following exhibits are being filed as part of this Quarterly Report on Form

On September 12, 2011, we filed with the Securities and Exchange Commission a Current Report on Form 8-K in which we disclosed our sale of our Indian subsidiary, our agreements with Futenco, the resignation of certain of our Directors and other matters.

We refer readers to such from 8-K for further information on such disclosed matters.

The following exhibits are being filed as part of this Quarterly Report on Form 10-Q.

Exhibit Description

13a-14(a)/15d-14(a) Certification of Principal Executive

13a-14(a)/15d-14(a) Certification of Principal Financial

1350 Certification of Principal Executive Officer.

1350 Certification of Principal Financial

to the requirements of the Securities Exchange Act of 1934, the registrant has

duly caused this report to be signed on its behalf by the undersigned thereunto

duly authorized.

Agreement, executed by Clenergen Corporation on September 5, 2011 and by Futenco [Incorporated by reference to Exhibit 10.1 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the Securities and Exchange Commission on September 12, 2011.]

Transfer Agreement, effective as of September 5, 2011, between Clenergen Corporation and Maxrise Powergen Limited.

[Incorporated by reference to Exhibit 10.2 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Shareholders Agreement, effective as of September 5, 2011, between Clenergen Corporation and Futenco.

[Incorporated by reference to Exhibit 10.3 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Shareholders Agreement, effective as of September 5, 2011, between Clenergen Corporation and Futenco.

[Incorporated by reference to Exhibit 10.4 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Shareholders Agreement, effective as of August 31, 2011, between Clenergen Corporation and Futenco.

[Incorporated by reference to Exhibit 10.5 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

License Agreement, effective as of September 1, 2011, between Clenergen Corporation and Futenco.

[Incorporated by reference to Exhibit 10.6 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Agreement, dated May 17, 2011, between Clenergen India Private Limited and Vastani Company S.A.

[Incorporated by reference to Exhibit 10.7 to the Quarterly Report on Form 10-Q of Clenergen Corporation, filed with the SEC on September 19, 2011.]

Rule 13a-14(a)/15d-14(a) Certification of Principal Executive Officer.

Rule 13a-14(a)/15d-14(a) Certification of Principal Financial Officer.

Section 1350 Certification of Principal Executive Officer.

Section 1350 Certification of Principal Financial Officer.

Resignation letter dated September 5, 2011, of Alex Worrall.

[Incorporated by reference to Exhibit 99.1 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Resignation letter dated September 5, 2011, of Sanil Kumar.

[Incorporated by reference to Exhibit 99.2 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Resignation letter dated September 5, 2011, of Pamela Peeters.

[Incorporated by reference to Exhibit 99.3 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Resignation letter dated September 5, 2011, of David Sonnenberg.

[Incorporated by reference to Exhibit 99.4 to the Current Report on Form 8-K (Date of Report:

September 5, 2011) of Clenergen Corporation, filed with the SEC on September 12, 2011.]

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Dated September 20, 2011

Clenergen Corporation

/s/ Mark L.M.

Chairman of the Board of Directors

Authorized Officer

Principal Executive Officer)

Chief Financial Officer

Financial and Accounting

Executive Chairman and Chief Executive Officer of the Board

(Duly Authorized Officer

and Principal Executive Officer)

/s/ Mike Starkie

Acting Chief Financial Officer

(Principal Financial and Accounting Officer)

Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.

What changed 10-Q/A

Item 5. Other Information